Alpha granule proteins in type I von Willebrand's disease
โ Scribed by Laurie P. McKeown; Sybil B. Williams; Brenda Shafer; Natalie Murray; Dr. Harvey R. Gralnick
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 330 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
While patients with type 2B von Willebrand's disease often exhibit thrombocytopenia, platelet morphology is typically normal. We describe a 44-year-old Jamaican man with thrombocytopenia and a history of bleeding, who had giant platelets on his peripheral blood film. Functional studies and von Wille
DDAVP is effective treatment in most types of von Willebrand's disease; however, in type 28 von Willebrand's disease the use of DDAVP has been contraindicated due to DDAVPinduced thrombocytopenla. Several reports have confirmed the thrombocytopenic effects of DDAVP and the presence of circulating pl
Type 2B von Willebrand's disease (VWD) is due to a qualitative defect in von Willebrand factor (VWF) in which there is an increased affinity for the platelet glycoprotein Ib-IX-V receptor complex. Spontaneous binding of type 2B VWF to platelets and subsequent clearance from the plasma is thought to
## Abstract Marked thrombocytopenia developed during pregnancy in both identical twins mothers who had systemic lupus erythematosus (SLE) and also type IIB von Willebrand's disease (vWD). The proband's platelet count decreased in the third trimester of pregnancy. Largeโdose ฮณโglobulin and predniso